Mostrar el registro sencillo del ítem

dc.contributor.authorSoto Hermida, Angel
dc.contributor.authorFernández Moreno, Mercedes
dc.contributor.authorOREIRO VILLAR, NATIVIDAD 
dc.contributor.authorFernández López, Carlos
dc.contributor.authorPertega Diaz, Sonia 
dc.contributor.authorCortes Pereira, Estefania
dc.contributor.authorRego Pérez, Ignacio 
dc.contributor.authorBLANCO GARCIA, FRANCISCO JAVIER 
dc.date.accessioned2017-06-07T06:53:07Z
dc.date.available2017-06-07T06:53:07Z
dc.date.issued2014
dc.identifier.issn1932-6203
dc.identifier.urihttp://hdl.handle.net/20.500.11940/206
dc.description.abstractObjective: To evaluate the influence of the mtDNA haplogroups on knee osteoarthritis progression in Osteoarthritis Initiative (OAI) participants through longitudinal data from radiographs and magnetic resonance imaging (MRI). Methods: Four-year knee osteoarthritis progression was analyzed as increase in Kellgren and Lawrence (KL) grade, in addition to increase in OARSI atlas grade for joint space narrowing (JSN), osteophytes and subchondral sclerosis in the tibia medial compartment of 891 Caucasian individuals from the progression subcohort. The influence of the haplogroups on the rate of structural progression was also assessed as the four-year change in minimum joint space width (mJSW in millimetres) in both knees of (n = 216) patients with baseline unilateral medial-tibiofemoral JSN. Quantitative cartilage measures from longitudinal MRI data were those related to cartilage thickness and volume with a 24 month follow-up period (n = 381). Results: During the four-year follow-up period, knee OA patients with the haplogroup T showed the lowest increase in KL grade (Hazard Risk [HR] = 0.499; 95% Confidence Interval [CI]: 0.261-0.819; p<0.05) as well as the lowest cumulative probability of progression for JSN (HR = 0.547; 95% CI: 0.280-0.900; p<0.05), osteophytes (HR = 0.573; 95% CI: 0.304-0.893; p<0.05) and subchondral sclerosis (HR = 0.549; 95% CI: 0.295-0.884; p<0.05). They also showed the lowest decline in mJSW (standardized response means (SRM) = -0.39; p = 0.037) in those knees without baseline medial JSN (no-JSN knees). Normalized cartilage volume loss was significantly lower in patients carrying the haplogroup T at medial tibia femoral (SRM = -0.33; p = 0.023) and central medial femoral (SRM = -0.27; p = 0.031) compartments. Cartilage thickness loss was significantly lower in carriers of haplogroup T at central medial tibia-femoral (SRM = -0.42; p = 0.011), medial tibia femoral (SRM = -0.32; p = 0.018), medial tibia anterior (SRM = +0.31; p = 0.013) and central medial femoral (SRM = -0.19; p = 0.013) compartments. Conclusions: Mitochondrial genome seems to play a role in the progression of knee osteoarthritis. mtDNA variation could improve identification of patients predisposed to faster or severe progression of the disease.
dc.description.sponsorshipFundación Española de Reumatología
dc.description.sponsorshipFondo de Investigación Sanitaria
dc.description.sponsorshipMinisterio de Ciencia e Innovación
dc.description.sponsorshipOstearthritis Inititative
dc.description.sponsorshipPfizer
dc.description.sponsorshipNovartis Pharmaceuticals
dc.description.sponsorshipMerck Research Laboratories
dc.description.sponsorshipGlaxoSmitheKline
dc.language.isoeng
dc.rightsAtribución 4.0 Internacional
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subject.meshDNA, Mitochondrial
dc.subject.meshGenome, Mitochondrial
dc.subject.meshOsteoarthritis, Knee
dc.titleMitochondrial DNA (mtDNA) haplogroups influence the progression of knee osteoarthritis. Data from the Osteoarthritis Initiative (OAI)
dc.typeArtigoes
dc.authorsophosSoto-Hermida, A.
dc.authorsophosFernandez-Moreno, M.
dc.authorsophosOreiro, N.
dc.authorsophosFernandez-Lopez, C.
dc.authorsophosPertega, S.
dc.authorsophosCortes-Pereira, E.
dc.authorsophosRego-Perez, I.
dc.authorsophosBlanco, F. J.
dc.identifier.doi10.1371/journal.pone.0112735
dc.identifier.pmid25390621
dc.identifier.sophos15715
dc.issue.number11
dc.journal.titlePLoS One
dc.organizationServizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de A Coruña::INIBIC.- Instituto de Investigación Biomédica
dc.organizationServizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de A Coruña - Complexo Hospitalario Universitario A Coruña::Epidemioloxía
dc.page.initiale112735
dc.relation.projectIDFIS/CIBERCB06/01/0040
dc.relation.projectIDFIS/PI08/2028
dc.relation.projectIDMinisterio Ciencia e Innovación/PLE2009-0144
dc.relation.projectIDFIS/CP12/03192
dc.relation.projectIDOstoarthritis Initiative/NO1-AR-2-2258
dc.relation.projectIDOstoarthritis Initiative/NO1-AR-2-2259
dc.relation.projectIDOstoarthritis Initiative/NO1-AR-2-2260
dc.relation.projectIDOstoarthritis Initiative/NO1-AR-2-2261
dc.relation.projectIDOstoarthritis Initiative/NO1-AR-2-2262
dc.rights.accessRightsopenAccess
dc.subject.decsOsteoartritis de la Rodilla
dc.subject.decsGenoma Mitocondrial
dc.subject.decsADN Mitocondrial
dc.subject.decsHaplotypes
dc.subject.decsHaplotipos
dc.typesophosArtículo Original
dc.volume.number9


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución 4.0 Internacional